Elevated and diagnostic androgens of polycystic ovary syndrome

Ibrahim Abdelazim; Ahmed Alanwar; Mohannad AbuFaza; Osama Amer; Yerbol Bekmukhambetov; Gulmira Zhurabekova; Svetlana Shikanova; Bakyt Karimova

doi:10.5114/pm.2020.95293

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2020
vol. 19

Send email

Copy url:

abstract:

Original paper

Elevated and diagnostic androgens of polycystic ovary syndrome

Ibrahim A. Abdelazim

^{1, 2}

,

Ahmed Alanwar

¹

,

Mohannad AbuFaza

²

,

Osama O. Amer

³

,

Yerbol Bekmukhambetov

⁴

,

Gulmira Zhurabekova

⁵

,

Svetlana Shikanova

⁶

,

Bakyt Karimova

⁶

Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
Department of Obstetrics and Gynecology, Ahmadi Hospital, Kuwait Oil Company (KOC), Ahmadi, Kuwait
Department of Oncology, Ghamra Military Hospital, Cairo, Egypt
Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Normal and Topographic Anatomy, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Obstetrics and Gynecology No. 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

Menopause Rev 2020; 19(1): 1-5

DOI: https://doi.org/10.5114/pm.2020.95293

Online publish date: 2020/04/27

View full text Get citation

PlumX metrics:

Introduction
A genetic variation at the level of aromatase enzyme and/or androgen receptors was suggested in polycystic ovary syndrome (PCOS).

Aim of the study
To determine the androgens elevated and diagnostic for PCOS.

Material and methods
A total of 120 PCOS women were compared to non-PCOS controls in this study. The studied women were evaluated thoroughly, including: day 2-3 hormonal profile and any hormonal change confirmed by two laboratory results eight weeks apart. Collected data were analysed to determine the androgens elevated and diagnostic for PCOS.

Results
The luteinising hormone (LH) and LH/follicle stimulating hormone (FSH) ratio were significantly high in the studied PCOS group compared to controls (p = 0.02 and 0.01, respectively). In addition, total and free testosterone and androstenedione were significantly high in the studied PCOS group compared to controls (p = 0.001, 0.003, and 0.02, respectively). The studied PCOS group had higher relative risk (RR) and odds ratio (OR) of elevated total testosterone (2.4 and 5.7, respectively), elevated free testosterone (2.9 and 4.9, respectively), and elevated androstenedione (3.0 and 4.8, respectively), compared to controls.

Conclusions
Testosterone (both total and free testosterone) and androstenedione were the main elevated androgens and were diagnostic for excess ovarian androgens in the studied PCOS women, whereas dehydroepiandrosterone (DHEA) was not elevated and/or diagnostic for excess ovarian androgens in the studied PCOS women.

keywords:

Elevated and diagnostic androgens of polycystic ovary syndrome

Ibrahim A. Abdelazim 1, 2 , Ahmed Alanwar 1 , Mohannad AbuFaza 2 , Osama O. Amer 3 , Yerbol Bekmukhambetov 4 , Gulmira Zhurabekova 5 , Svetlana Shikanova 6 , Bakyt Karimova 6

elevated, diagnostic, androgens, PCOS

Ibrahim A. Abdelazim

^{1, 2}

,

Ahmed Alanwar

¹

,

Mohannad AbuFaza

²

,

Osama O. Amer

³

,

Yerbol Bekmukhambetov

⁴

,

Gulmira Zhurabekova

⁵

,

Svetlana Shikanova

⁶

,

Bakyt Karimova

⁶